Artificial Intelligence (AI)-Powered Prosthetics Market Report 2025

The artificial intelligence (AI)-powered prosthetics market size has grown rapidly in recent years. It will grow from $1.47 billion in 2024 to $1.71 billion in 2025 at a compound annual growth rate (CAGR) of 16.3%. The growth in the historic period can be attributed to the rising prevalence of diabetes-related amputations, increasing demand for advanced mobility solutions, higher incidence of traumatic limb loss injuries, growing investment in bionic technologies, and the expanding adoption of myoelectric prosthetics.

The artificial intelligence (AI)-powered prosthetics market size is expected to see rapid growth in the next few years. It will grow to $3.08 billion in 2029 at a compound annual growth rate (CAGR) of 15.9%. The growth in the forecast period can be attributed to the increasing adoption of brain-computer interface technology, rising demand for personalized prosthetic solutions, growing investment in AI-driven rehabilitation technologies, expanding applications of machine learning in prosthetics, and rising government support for assistive technologies. Major trends during this period include advancements in neural control interfaces, development of lightweight smart materials, innovation in self-learning prosthetic algorithms, expansion of 3D-printed customizable solutions, and the emergence of affordable AI-powered bionic limbs.

The rising incidence of diabetes is expected to drive growth in the artificial intelligence (AI)-powered prosthetics market in the coming years. Diabetes, a chronic condition characterized by elevated blood sugar levels due to insufficient insulin production or inefficient insulin use, is increasing largely because of sedentary lifestyles. Reduced physical activity slows metabolism and contributes to weight gain, raising the risk of insulin resistance. Diabetes complications, including poor circulation and nerve damage, can lead to limb amputations, thereby increasing demand for AI-powered prosthetics that restore mobility and improve quality of life. For example, according to the National Health Service (NHS) in June 2024, the number of individuals identified in England with pre-diabetes reached 3,615,330 in 2023, an 18% increase from 3,065,825 in 2022. Among people under 40, cases rose nearly 25%, from 173,166 in 2022 to 216,440 in 2023. This trend is fueling demand for AI-powered prosthetics.

Key players in the AI-powered prosthetics market are developing advanced technologies, such as neural interface integration, to enhance limb functionality and provide amputees with near-natural mobility. Neural interface integration uses AI systems to decode brain or muscle signals via machine learning algorithms and sensor networks, enabling real-time, intuitive control of prosthetic limbs with life-like precision and responsiveness. For instance, in May 2025, Esper Bionics, a Ukraine-based bionic prosthetics company, launched the Esper Hand 2, an AI-powered, waterproof prosthetic hand that adapts to user behavior, delivers advanced grip strength, and functions effectively in challenging environments, including wet conditions. This innovation represents a significant advancement in assistive prosthetic technology, offering users intelligent, durable solutions for daily activities.

In February 2024, Nippon Express Holdings, a Japan-based logistics and transportation company, acquired an equity stake in Instalimb Inc. for an undisclosed amount. This investment aims to support Instalimb’s global expansion and enhance access to affordable AI-driven 3D-printed prosthetic devices in emerging markets. Instalimb Inc., a Japan-based startup, specializes in low-cost, high-quality 3D-printed prosthetics that leverage AI and additive manufacturing to broaden accessibility and improve mobility for amputees worldwide.

Major players in the artificial intelligence (AI)-powered prosthetics market are Ottobock SE & Co. KGaA, Össur hf, Blatchford Limited, BrainCo Inc., BrainRobotics Inc., Open Bionics Ltd., Point Designs Inc., Ambionics Ltd., Coapt LLC, Vincent Systems GmbH, PSYONIC Inc., BionIT Labs Ltd., Aether Biomedical Inc., BionicM Inc., Esper Bionics Inc., Mobius Bionics LLC, Covvi Limited, Unlimited Tomorrow Inc., Prensilia S.r.l., and Bioniks Pvt. Ltd.

North America was the largest region in the artificial intelligence (AI)-powered prosthetics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in artificial intelligence (AI)-powered prosthetics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the artificial intelligence (AI)-powered prosthetics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

Artificial intelligence (AI)-powered prosthetics are advanced limb replacements that leverage AI to improve mobility, adaptability, and user control, moving beyond reliance on pre-programmed movements. Their main objective is to restore near-natural functionality for amputees by interpreting and responding to muscle signals, neural inputs, and environmental cues.

The primary types of AI-powered prosthetics include implantable and non-implantable prostheses. An implantable prosthesis is a medical device surgically placed inside the body to replace or support a missing or damaged organ, joint, or tissue. These prosthetics employ technologies such as microprocessor-controlled systems, myoelectric controls, robotic mechanisms, electric-powered designs, and hybrid solutions. They are applied in amputee mobility, rehabilitation, sports prosthetics, military use, and daily activities. Key end users include hospitals, prosthetic clinics, rehabilitation centers, and related facilities.

The artificial intelligence (AI)-powered prosthetics market research report is one of a series of new reports that provides artificial intelligence (AI)-powered prosthetics market statistics, including the artificial intelligence (AI)-powered prosthetics industry global market size, regional shares, competitors with the artificial intelligence (AI)-powered prosthetics market share, detailed artificial intelligence (AI)-powered prosthetics market segments, market trends, and opportunities, and any further data you may need to thrive in the artificial intelligence (AI)-powered prosthetics industry. This artificial intelligence (AI)-powered prosthetics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The artificial intelligence (AI)-powered prosthetics market consists of revenues earned by entities by providing services such as bionic limb manufacturing, neural interface integration, rehabilitation support, and training. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI)-powered prosthetics market also includes sales of bionic limbs, neural sensors, advanced prosthetic materials, and AI-driven control systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.